Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Gray Sheet

Executive Summary

"Debtor-in-possession" credit facility for up to $38.8 mil. is secured following the filing of a voluntary Chapter 11 bankruptcy petition in Delaware federal court. The financing will provide the medical/surgical supply maker and distributor with sufficient liquidity to pay suppliers for "post-petition" goods and services, meet payroll, and carry it through completion of its debt restructuring, the firm says. The bankruptcy petition coincides with the resignations of John McGregor as president and CEO, and of Robert Gluck as chief financial officer. David Hilton was named to replace McGregor. Hilton is known as a turn-around specialist and formerly headed J.E. Morgan Knitting Mills. Rothschild, Inc. has been retained to provide investment-banking services

You may also be interested in...

Graham-Field Health Products, Inc.

Replacement $35 mil. "debtor-in-possession" financing agreement with Congress Financial Corporation closes April 17. The new financing arrangement replaces the current DIP loan serviced by IBJ Whitehall Business Credit Corporation, secured following a Chapter 11 bankruptcy filing in Delaware federal court, and includes more favorable terms (1"The Gray Sheet" Jan. 10, p. 10). "It is obvious that the financial community has strong faith in the company's ability to emerge from its Chapter 11 voluntary bankruptcy position as an on-going concern," CEO David Hilton commented

Health And Wellness Trademark Review 1 December, 2020

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts